Tonghua Dongbao Pharmaceutical (600867.SH) announced that by December 31, 2024, the company will complete 2024...
According to a report from the Zhixing Finance APP, Tonghua Dongbao Pharmaceutical (600867.SH) announced that by December 31, 2024, the company completed the second phase of share repurchase for 2024, and the share repurchase plan has been fully implemented. A total of 23.1912 million shares were repurchased, accounting for 1.17% of the company's total equity. The highest repurchase price was 8.45 yuan per share, the lowest price was 7.32 yuan per share, and the average repurchase price was 7.76 yuan per share, with a total funding amount of 0.18 billion yuan (excluding transaction fees).